PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Acid suppression (Adults) (Omeprazole - Acid suppression (Adults))
Records returned : 15 (on 07 Nov 2024 at 09:24:22). Return to search results for ' Acid suppression (Adults) '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
01.03.05
Green
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Preferred
1st line for patients with no swallowing difficulties.
Non Formulary
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Omeprazole or lansoprazole capsules are 1st-line.
Pantoprazole or rabeprazole tablets are 2nd-line for patients without swallowing difficulties (suitable for patients that cannot have animal-derived products).
Non Formulary
Formulations :
- Oral suspension
- Oro-dispersible
ASPH
RSFT
SASH
SABP
Primary Care
Important
Omeprazole capsules can be opened for patients with swallowing difficulties.
Lansoprazole oro-dispersible tablets are 1st-line for patients with enteral feeding tubes
01.03.01
Green
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Preferred
01.03.05
Green
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Preferred
1st line for patients with no swallowing difficulties.
2nd line for adults with swallowing difficulties / feeding tubes - capsules can be opened.
Green (see narrative)
Formulations :
- Oro-dispersible
ASPH
RSFT
SASH
SABP
Primary Care
Important
Preferred
1st line in adults with swallowing difficulties.
1st line for patients with enteral feeding tubes.
01.03.05
Green (see narrative)
Formulations :
- Granules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Lansoprazole oro-dispersible 1st-line. Esomeprazole is 3rd-line. Restricted to patients with swallowing difficulties or with large bore enteral feeding tube when other options are not clinically appropriate. Do not use in tubes less than 6F.
01.03.01
Green (see narrative)
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Preferred
For use where a PPI is not suitable and an H2RA is indicated.
For doses of 300mg, please prescribe 2x150mg as this is considerably more cost effective.
01.03.01
Green (see narrative)
Formulations :
- Oral solution
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Reserve for use where a PPI AND and other H2RAs are not suitable OR where a liquid preparation is required.
Check for drug interactions.
01.03.05
Green (see narrative)
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
01.03.05
Green (see narrative)
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
01.03.05
Green (see narrative)
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Important
Lansoprazole capsules are the preferred option.
Esomeprazole 40mg restricted to short-term use or for Zollinger-Ellison syndrome.
Non Formulary
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
01.03.01
Non Formulary
Formulations :
- Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
01.03.05
Non Formulary
Formulations :
- Liquid
- Oral solution
- Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
Important
Lansoprazole oro-dispersible tablets are 1st-line for adults with swallowing dificulties or enteral feeding tubes.
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients